These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38606933)
101. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells. Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726 [TBL] [Abstract][Full Text] [Related]
102. Development of a Novel Orthotopic Gastric Cancer Mouse Model. Kang W; Maher L; Michaud M; Bae SW; Kim S; Lee HS; Im SA; Yang HK; Lee C Biol Proced Online; 2021 Jan; 23(1):1. PubMed ID: 33390162 [TBL] [Abstract][Full Text] [Related]
103. A TRAMP-derived orthotopic prostate syngeneic (TOPS) cancer model for investigating anti-tumor treatments. Lardizabal J; Ding J; Delwar Z; Rennie PS; Jia W Prostate; 2018 May; 78(6):457-468. PubMed ID: 29450905 [TBL] [Abstract][Full Text] [Related]
104. Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration. Frost GI; Lustgarten J; Dudouet B; Nyberg L; Hartley-Asp B; Borgström P Microvasc Res; 2005 Jan; 69(1-2):1-9. PubMed ID: 15797254 [TBL] [Abstract][Full Text] [Related]
105. Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma. Patel SJ; Molinolo AA; Gutkind S; Crawford NP PLoS One; 2013; 8(4):e61848. PubMed ID: 23620793 [TBL] [Abstract][Full Text] [Related]
106. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. Pittoni P; Tripodo C; Piconese S; Mauri G; Parenza M; Rigoni A; Sangaletti S; Colombo MP Cancer Res; 2011 Sep; 71(18):5987-97. PubMed ID: 21896641 [TBL] [Abstract][Full Text] [Related]
107. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice. Sun F; Zhang ZW; Tan EM; Lim ZLR; Li Y; Wang XC; Chua SE; Li J; Cheung E; Yong EL Carcinogenesis; 2016 Jul; 37(7):701-711. PubMed ID: 27207661 [TBL] [Abstract][Full Text] [Related]
108. An orthotopic prostate cancer model for new treatment development using syngeneic or patient-derived tumors. Chaudary N; Wiljer E; Foltz W; Thapa P; Hill RP; Milosevic M Prostate; 2024 Jun; 84(9):823-831. PubMed ID: 38606933 [TBL] [Abstract][Full Text] [Related]